Symbol="CMMB"
AssetType="Common Stock"
Name="Chemomab Therapeutics Ltd DRC"
Description="Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company is headquartered in Tel Aviv, Israel."
CIK="1534248"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5 KIRYAT HAMADA ST, PO BOX 45032, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="13701800"
EBITDA="-32201000"
PERatio="None"
PEGRatio="None"
BookValue="2.53"
DividendPerShare="0"
DividendYield="0"
EPS="-2.7"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.42"
ReturnOnEquityTTM="-0.735"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="25"
TrailingPE="-"
ForwardPE="13.0"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.62"
EVToRevenue="-"
EVToEBITDA="0.747"
Beta="-0.28"
num_52WeekHigh="4.14"
num_52WeekLow="1"
num_50DayMovingAverage="1.482"
num_200DayMovingAverage="1.827"
SharesOutstanding="11049800"
DividendDate="None"
ExDividendDate="None"
symbol="CMMB"
open="1.23"
high="1.25"
low="1.18"
price="1.25"
volume="15718.00"
latest_trading_day="2023-08-03"
previous_close="1.24"
change="0.01"
change_percent="0.8065%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="83"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="17"
Volume_recent_avg="125003"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_30"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="17"
Aroon_momentum_negative="83"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="542"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_positive_thumbnail_id_1="953"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_positive_thumbnail_id_2="965"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
